Spine Capital Equipment Sales Leader (Remote)

Johnson Johnson; Raynham (MA); On-site; USD 114,000 - 183,000; Full time

Benefits offered by this job

Vacation 120 hours / year

Sick time 40–56 hours / year (US)

Floating holidays 13 days / year

Parental Leave - 480 hours

Job summary

Johnson & Johnson is seeking a Capital Equipment Sales Manager, Spine to lead end-to-end commercialization of DePuy Synthes capital platforms in Spine. The role covers territory planning, technology demonstrations, and negotiating capital acquisition options with surgeons and economic buyers.

You will partner with local field sales and strategic accounts to drive adoption, ensure clinical and economic goals are met, and travel up to 75% to support customers across major US markets.

Qualifications

• Bachelor’s degree or equivalent required; 8+ years of relevant experience acceptable.
• Capital equipment sales, marketing or commercialization experience preferred.
• Willingness to travel up to 75% and work in hospital/ASC settings with protective gear.

Responsibilities

• Develop and execute quarterly business plans for assigned accounts.
• Identify and convert capital sales opportunities in the territory.
• Negotiate pricing and terms for capital equipment.
• Collaborate with cross-functional teams to align sales strategies.

Skills

Brand positioning

Brand recognition

Commercial awareness

Competitive landscape

Confidentiality

Financial reports

Interpersonal influence

Market opportunity

Process improvements

Report writing

Sales enablement

Sales prospecting

Strategic sales planning

Strategic thinking

Sustainable procurement

Technical credibility

Vendor selection

Education

Bachelor’s degree or equivalent

Job description

Johnson & Johnson is seeking a Capital Equipment Sales Manager, Spine to lead end-to-end commercialization of DePuy Synthes capital platforms in Spine. The role covers territory planning, technology demonstrations, and negotiating capital acquisition options with surgeons and economic buyers.

You will partner with local field sales and strategic accounts to drive adoption, ensure clinical and economic goals are met, and travel up to 75% to support customers across major US markets.